SEOUL, April 29 (Reuters) - South Korea's drug safety ministry said on Thursday that Russia's Sputnik V coronavirus vaccine and a shot developed by Novavax have been submitted for preliminary regulatory approval.
(Reporting by Hyonhee Shin; editing by John Stonestreet)
((hyonhee.shin@thomsonreuters.com; 822 3704 5658;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments